Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract

详细信息	查看全文 | 推荐本文 |

• 作者：Carlos Sostres ; MD^a ; ^b ; ^{carlossostres@gmail.com} ; Carla J. Gargallo ; MD^a (Research Fellow)
• 关键词：Low-dose aspirin ; Gastrointestinal bleeding ; Mortality ; Time trends
• 刊名：Best Practice Research Clinical Gastroenterology
• 出版年：2012
• 期刊代码：35_15216918
• 类别：med
• 出版时间：April, 2012
• 卷：26
• 期：2
• 页码：141-151
• 文件大小：328 K

摘要

Low dose aspirin (ASA) use has been associated with a wide range of adverse side effects in the upper gastrointestinal (GI) tract, which range from troublesome symptoms without mucosal lesions to more serious toxicity, including ulcers, GI bleeding, perforation and even death. Upper GI symptoms in low dose ASA users are common but often careless or misinterpreted and they are not always related to the presence of mucosal injury. Usually, low dose ASA related ulcers are reasonably small and asymptomatic, and probably heal over a period of weeks to a few months. But, the real clinical problem occurs when the ulcer results in a GI complication (mostly bleeding). The estimated average excess risk of symptomatic or complicated ulcer related to low dose ASA is five cases per 1000 ASA users per year. Death is the worst outcome of GI complications in low dose ASA users, but data about this aspect are scarce. Current evidence indicates that low dose ASA can damage the lower GI tract also, but the real size of the problem is still unknown.